These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 20693194)

  • 21. Apo material as a trigger for inflammation in systemic lupus erythematosus.
    Meesmann HM; Parcina M; Lorenz HM; Blank N; Schiller M
    Autoimmunity; 2009 May; 42(4):251-3. PubMed ID: 19811267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosus.
    Mackern-Oberti JP; Llanos C; Riedel CA; Bueno SM; Kalergis AM
    Immunology; 2015 Dec; 146(4):497-507. PubMed ID: 26173489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cause and consequences of the activated type I interferon system in SLE.
    Eloranta ML; Rönnblom L
    J Mol Med (Berl); 2016 Oct; 94(10):1103-1110. PubMed ID: 27094810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating Apoptotic Microparticles in Systemic Lupus Erythematosus Patients Drive the Activation of Dendritic Cell Subsets and Prime Neutrophils for NETosis.
    Dieker J; Tel J; Pieterse E; Thielen A; Rother N; Bakker M; Fransen J; Dijkman HB; Berden JH; de Vries JM; Hilbrands LB; van der Vlag J
    Arthritis Rheumatol; 2016 Feb; 68(2):462-72. PubMed ID: 26360137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monogenic systemic lupus erythematosus: insights in pathophysiology.
    Batu ED
    Rheumatol Int; 2018 Oct; 38(10):1763-1775. PubMed ID: 29766256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in the genetics of systemic lupus erythematosus.
    Flesher DL; Sun X; Behrens TW; Graham RR; Criswell LA
    Expert Rev Clin Immunol; 2010 May; 6(3):461-79. PubMed ID: 20441431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pathogenesis of systemic lupus erythematosus].
    Alexander T; Radbruch A; Hiepe F
    Z Rheumatol; 2015 Apr; 74(3):183-90. PubMed ID: 25854151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Type-I interferons and systemic lupus erythematosus.
    Koutouzov S; Mathian A; Dalloul A
    Autoimmun Rev; 2006 Oct; 5(8):554-62. PubMed ID: 17027892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Interferon-alpha: a key cytokine in systemic lupus erythematosus pathogenesis].
    Mathian A; Koutouzov S
    Rev Med Interne; 2008 Sep; 29(9):696-700. PubMed ID: 18524426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Humoral markers of active Epstein-Barr virus infection associate with anti-extractable nuclear antigen autoantibodies and plasma galectin-3 binding protein in systemic lupus erythematosus.
    Rasmussen NS; Nielsen CT; Houen G; Jacobsen S
    Lupus; 2016 Dec; 25(14):1567-1576. PubMed ID: 27084029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type I interferon and T helper 17 cells co-exist and co-regulate disease pathogenesis in lupus patients.
    Biswas PS; Aggarwal R; Levesque MC; Maers K; Ramani K
    Int J Rheum Dis; 2015 Jul; 18(6):646-53. PubMed ID: 25960196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNA-seq Analysis Reveals Unique Transcriptome Signatures in Systemic Lupus Erythematosus Patients with Distinct Autoantibody Specificities.
    Rai R; Chauhan SK; Singh VV; Rai M; Rai G
    PLoS One; 2016; 11(11):e0166312. PubMed ID: 27835693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibodies in systemic lupus erythematosus.
    Elkon K
    Curr Opin Rheumatol; 1995 Sep; 7(5):384-8. PubMed ID: 8519610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and stratification of systemic lupus erythematosus patients into two transcriptionally distinct clusters based on IFN-I signature.
    Shobha V; Mohan A; Malini AV; Chopra P; Karunanithi P; Subramani Thulasingam S; Selvam S; Deyati A; Srivastava R; Basavanthappa S; Lemos N; Sunitha SM; Mazumder Tagore D; Anand A; Pant S; Jayaswal V; Ramarao M; Dudhgaonkar S
    Lupus; 2021 Apr; 30(5):762-774. PubMed ID: 33497307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-class a scavenger receptor autoantibodies from systemic lupus erythematosus patients impair phagocytic clearance of apoptotic cells by macrophages in vitro.
    Chen XW; Shen Y; Sun CY; Wu FX; Chen Y; Yang CD
    Arthritis Res Ther; 2011 Jan; 13(1):R9. PubMed ID: 21281474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The important roles of type I interferon and interferon-inducible genes in systemic lupus erythematosus.
    Luo S; Wang Y; Zhao M; Lu Q
    Int Immunopharmacol; 2016 Nov; 40():542-549. PubMed ID: 27769023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of apoptosis in autoimmunity: immunogen, antigen, and accelerant.
    Levine JS; Koh JS
    Semin Nephrol; 1999 Jan; 19(1):34-47. PubMed ID: 9952279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tolerogenic dendritic cells: role and therapeutic implications in systemic lupus erythematosus.
    Mok MY
    Int J Rheum Dis; 2015 Feb; 18(2):250-9. PubMed ID: 25639676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease.
    Mavragani CP; Sagalovskiy I; Guo Q; Nezos A; Kapsogeorgou EK; Lu P; Liang Zhou J; Kirou KA; Seshan SV; Moutsopoulos HM; Crow MK
    Arthritis Rheumatol; 2016 Nov; 68(11):2686-2696. PubMed ID: 27338297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory clearance of apoptotic remnants in systemic lupus erythematosus (SLE).
    Janko C; Schorn C; Grossmayer GE; Frey B; Herrmann M; Gaipl US; Munoz LE
    Autoimmun Rev; 2008 Oct; 8(1):9-12. PubMed ID: 18703173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.